Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers

May 10, 2018
Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …

News
michael_cohen

Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer

May 9, 2018
Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 4, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, EMA, Kymriah, Novartis, Porton Biopharma, Regeneron, Roche, Sandoz, Sanofi, Shire, Takeda, biosimilars, dementia

It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …

News

Sandoz US woes continue with biosimilar rejection

May 3, 2018
Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical

In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …

News
novartis_window

Novartis becomes first to gain second CAR T indication

May 2, 2018
Research and Development, Sales and Marketing Gilead, Kymriah, Novartis, Yescarta, biotech, drugs, pharma, pharmaceutical

Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of …

News
phone_health

Novartis forges forward into digital pharma with FocalView app

April 25, 2018
Medical Communications, Research and Development FocalView, Novartis, biotech, drugs, pharma, pharmaceutical

There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …

News
novartis_side_building

Novartis expands Pear partnership to tackle opioid and substance use disorder

April 23, 2018
Research and Development, Sales and Marketing Novartis, Pear Therapeutics, Sandoz, opioids, pharma, substance use disorder

Novartis has announced that it will expand its current partnership with Pear Therapeutics, signed in March, as it reveals that …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 20, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, EMA, GW Pharma, J&J, JJ, MHRA, Mylan, Novartis, Sanofi, Shire, Takeda, biotech, drugs, epipen, keytruda, pharma, pharmaceutical

It’s the end of another week and there’s really been one story that has dominated the headlines – Takeda’s potential …

News
john_tsai

Novartis snatches Amgen and BMS veteran for CMO and Drug Development Head

April 19, 2018
Medical Communications Amgen, BMS, Bristol-Myers Squibb, Novartis, appointment, pharma

Dr John Tsai has been welcomed to the fold as Novartis’ new Head of Global Development and Chief Medical Officer, …

News
amgen_flag

Amgen and Novartis’ Aimovig shines in migraine at Phase 3

April 18, 2018
Research and Development Aimovig, Amgen, Novartis, migraine, pharma

Amgen has lifted the curtain on complete Phase 3 data for its calcitonin gene-related peptide receptor (CGRP) inhibitor Aimovig (erenumab) in …

News
novartis_outside_1

Novartis to invest $100m in new malaria treatments

April 17, 2018
Manufacturing and Production, Research and Development Novartis, WHO, malaria, pharma

Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over …

News
novartis_outside_1

Novartis’ Entresto helps preserve kidney function in chronic heart failure patients

April 16, 2018
Research and Development, Sales and Marketing Entresto, Novartis, heart failure, pharma

Novartis has lifted the curtain on new data from a Phase 3 trial investigating the efficacy of Entresto (sacubitril/valsartan) in …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 13, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Cancer, Humira, Mylan, Novartis, Shire, Takeda, Teva, acquisition, cystic fibrosis, hepatitis C, pharma, top ten

It’s Friday the 13th, but that doesn’t change a strong showing from the industry this week as it continued to …

News

Novartis CEO makes mark with $8.7bn AveXis acquisition

April 9, 2018
Sales and Marketing AveXis, Novartis, biotech, drugs, gene therapy, pharma, pharmaceutical

Vas Narasimhan’s first few moves as CEO of Novartis indicate that he is not afraid to take bold risks in …

News

GSK to take control of Consumer Healthcare in £9.2bn buyout

March 27, 2018
Manufacturing and Production, Sales and Marketing Consumer Health Care, GSK, Novartis, biotech, drugs, horlicks, pharma, pharmaceutical

GSK has announced that it plans to purchase Novartis’ 36.5% stake in the joint Consumer Healthcare Business for a sum …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026